All Posts

A nurse's guide for patients, pharmacies, and referral partners Our nurses have spent their careers around infusions, first at the bedside in the ICU and then in patients' homes. In that time we have watched IVIG go from something most people had never heard of to one of the most commonly referred specialty therapies in home infusion. We have also watched a lot of confusion follow it around. Patients get a prescription, a pharmacy phone number, and a promise that a nurse will

DOMO Health Clinical Team, Durham, North Carolina Abstract Background. Recurrent pregnancy loss (RPL) affects a meaningful share of people trying to conceive, and many cases remain unexplained after evaluation. Intravenous immunoglobulin (IVIG) has been studied for unexplained RPL for more than three decades. It is not approved by the U.S. Food and Drug Administration (FDA) for this indication. Objective. To summarize the randomized evidence and current guideline positions on

An honest look at the evidence on IVIG for recurrent pregnancy loss, the questions to ask your specialist, and what home infusion involves if your doctor prescribes it.